Oregon Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 25 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 4,458
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 48.40%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 538
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 40.96%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 47.06% 54.65%
White, Hispanic/Latino Patients 20.52% 19.14%
Black/African American, Non-Hispanic/Latino Patients 2.69% 1.12%
Black/African American, Hispanic/Latino Patients 0.25% 0.19%
Asian Patients3 2.22% 2.23%
American Indian/Alaska Native Patients3 7.54% 5.39%
Native Hawaiian/Other Pacific Islander Patients3 0.61% 1.12%
Patients with More than one race3 3.45% 3.72%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.86% 5.02%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.48% 0.74%
Unreported/Refused to Report Race and Ethnicity 7.31% 6.69%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,638
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 58.07%
COVID-19 Immunization Series Completed 2,325
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 56.00%
COVID-19 Immunization Series Additional 485
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 18.73%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 36.63% 38.67% 66.19%
White, Hispanic/Latino Patients 24.85% 25.38% 7.84%
Black/African American, Non-Hispanic/Latino Patients 5.62% 5.85% 1.65%
Black/African American, Hispanic/Latino Patients 0.31% 0.09% 0.00%
Asian Patients3 1.53% 1.68% 2.06%
American Indian/Alaska Native Patients3 2.01% 1.85% 0.62%
Native Hawaiian/Other Pacific Islander Patients3 0.92% 0.77% 0.21%
Patients with More than one race3 1.53% 1.89% 2.06%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 13.98% 11.70% 0.82%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.20% 1.98% 3.30%
Unreported/Refused to Report Race and Ethnicity 10.44% 10.15% 15.26%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 36.00%
1 to 24 Hours 24.00%
More Than 24 Hours 40.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 4.00%
Staffing to administer the vaccine 36.00%
Vaccine confidence 40.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 4.00%
None 28.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 16.00%
Average Percent of Health Center Visits Conducted Virtually 27.80%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 32.00%
Number of Mobile Van Sites 11
Number of Pop-up Clinics 8
Number of School-Based Vaccination Sites 19

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 24.00%
Refer patients to another organization that provides monoclonal antibody therapies 28.00%
None 48.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.00%
Patient awareness/education 0.00%
Staffing capacity 24.00%
Therapy administration/onsite logistics 16.00%
Other 8.00%
None 52.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021